{"id":"CHEMBL1006","canonicalSmiles":"NCCCNCCSP(=O)(O)O","inchiKey":"JKOQGQFVAUAYPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMIFOSTINE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amifostine","Ethyol"],"synonyms":["Amifostine","Amifostine disulfide","Amifostine trihydrate","Ethiofos","Gammaphos","NSC-296961","WR-2721","WR-2721 TRIHYDRATE","YM-08310"],"crossReferences":{"DailyMed":["amifostine"],"PubChem":["11110755","144203628","147094","170465179","50105748","90341753"],"Wikipedia":["Amifostine"],"drugbank":["DB01143"],"chEBI":["2636"]},"count":36,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 36 investigational indications."}
{"id":"CHEMBL1026","canonicalSmiles":"CS(=O)(=O)O.Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1","inchiKey":"CVKUMNRCIJMVAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOLDOPAM MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL588","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corlopam","Fenoldopam mesylate"],"synonyms":["Fenoldopam mesilate","Fenoldopam mesylate","Fenoldopam methanesulfonate","SK&F 82526-J","SK&F-82526J","SK-82526-J"],"crossReferences":{"DailyMed":["fenoldopam%20mesylate"],"PubChem":["49681595"]},"count":1,"linkedTargets":{"rows":["ENSG00000184845"],"count":1},"linkedDiseases":{"rows":["HP_0001919","EFO_0001645"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and has 1 investigational indication."}
{"id":"CHEMBL106187","canonicalSmiles":"N=C(N)N[C@@H](C(=O)NCC(=O)N1CCC(c2cc(-c3cccc(Cl)c3Cl)n[nH]2)CC1)C1CCCCC1","inchiKey":"SSSXBBASYYVGCI-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL106187","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03957"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1077896","canonicalSmiles":"CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C","inchiKey":"ZKMNUMMKYBVTFN-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROPIVACAINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ropivacaine","TLC-590","TLC590","Tlc590"],"crossReferences":{"DailyMed":["ropivacaine%20hydrochloride"],"PubChem":["26758019"],"Wikipedia":["Ropivacaine"],"drugbank":["DB00296"],"chEBI":["8890"]},"childChemblIds":["CHEMBL1889140"],"count":24,"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0004710","EFO_0003869","HP_0030838","EFO_0000275","EFO_0004698","EFO_1001909","EFO_0003964","EFO_0003931","EFO_0002506","EFO_1001366","EFO_0004253","EFO_1000786","MONDO_0008903","EFO_0004616","EFO_1000652","EFO_0006510","EFO_0009552","EFO_0009620","EFO_0000400","EFO_1001250","EFO_0005762","HP_0000016","HP_0200042","HP_0012532","EFO_0003821","MONDO_0008170","MONDO_0008315","EFO_0000546","HP_0003040","EFO_0000432","EFO_0004209","EFO_0005251","EFO_1001792","EFO_0004214","MONDO_0007254","EFO_0008553","MONDO_0001056","EFO_0009507","EFO_0009514","HP_0001385","HP_0030834","EFO_0004143","HP_0001822","EFO_0000616","EFO_0009508","EFO_0006859","EFO_0001358","EFO_0009387","EFO_0003843","EFO_1000941","EFO_0000311","HP_0000713","EFO_0007149","HP_0030839","HP_0000138","EFO_0003766","EFO_0005611","MONDO_0001572","HP_0000023","EFO_0009615","HP_0003470"],"count":61},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 24 investigational indications."}
{"id":"CHEMBL1086863","canonicalSmiles":"OC[C@H]1O[C@H](O)[C@H](F)[C@@H](O)[C@@H]1O","inchiKey":"ZCXUVYAZINUVJD-UKFBFLRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDEOXYGLUCOSE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fludeoxyglucose"],"crossReferences":{"DailyMed":["fludeoxyglucose%20f-18"],"drugbank":["DB04282"],"chEBI":["49132"]},"childChemblIds":["CHEMBL1092067"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 2 investigational indications."}
{"id":"CHEMBL1093458","canonicalSmiles":"CC/C(=C(\\c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1","inchiKey":"MHJBZVSGOZTKRH-IZHYLOQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENDOXIFEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Endoxifen"],"crossReferences":{"chEBI":["80555"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1096237","canonicalSmiles":"COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C","inchiKey":"GMJWGJSDPOAZTP-MIDYMNAOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-188797","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Desacetylpaclitaxel","4-desacetylpaclitaxel 4-methyl carbonate","Bms-188797"],"crossReferences":{"drugbank":["DB12619"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL110691","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"QMBJSIBWORFWQT-DFXBJWIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORMADINONE ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"classes":["Carcinogenicity"],"year":1970},"tradeNames":[],"synonyms":["Chlormadinone","Chlormadinone acetate","NSC-92338"],"crossReferences":{"PubChem":["144204432","144207863","170465776","29215009","56422443","855775"],"chEBI":["31394"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom and  United States initially in 1970 due to Carcinogenicity."}
{"id":"CHEMBL1163085","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NC(=O)[C@@H](N)Cc2ccc(O)cc2)[C@@H](O)[C@H]1O","inchiKey":"MJZAZMKENKZBAJ-QTOWJTHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1163085","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03325"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1165268","canonicalSmiles":"O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I","inchiKey":"FFINMCNLQNTKLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODIPAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cholografin"],"synonyms":["Adipiodone","Iodipamide"],"crossReferences":{"PubChem":["11112428","144207053","170464888","47193872"],"Wikipedia":["Adipiodone"],"drugbank":["DB04711"]},"childChemblIds":["CHEMBL3989806","CHEMBL2104843","CHEMBL1200504","CHEMBL1200350"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1184904","canonicalSmiles":"C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)N2","inchiKey":"OAKGNIRUXAZDQF-TXHRRWQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETASPIMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPI-504","Retaspimycin"],"crossReferences":{"drugbank":["DB05626"],"chEBI":["71975"]},"childChemblIds":["CHEMBL377559"],"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["MONDO_0008903","Orphanet_44890","EFO_0000673","MONDO_0007254","EFO_0001378","EFO_0000305","EFO_0003085","EFO_0003060","EFO_0002617","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1186894","canonicalSmiles":"CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O","inchiKey":"VJZITPJGSQKZMX-XDPRQOKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMRUBICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amrubicin"],"crossReferences":{"Wikipedia":["Amrubicin"],"drugbank":["DB06263"]},"childChemblIds":["CHEMBL481958"],"count":9,"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000576","EFO_1000581","MONDO_0008903","EFO_0000702","MONDO_0007254","EFO_0001378","EFO_1001968","MONDO_0001187"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1200339","canonicalSmiles":"CNC[C@H](O)c1cccc(O)c1.Cl","inchiKey":"OCYSGIYOVXAGKQ-FVGYRXGTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLEPHRINE HYDROCHLORIDE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1215","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Afrin 4 hour nasal spray","Biomydrin","Biorphen","Fenilfar","Fenox","Mydfrin","Nazex","Neo-synephrine","Neosynephrine","Nostril","Nurofen sinus pain relief","Phenylephrine hydrochloride","Prefrin","Vazculep"],"synonyms":["Metaoxedrine chloride","Phenylephrine HCl","Phenylephrine hydrochloride"],"crossReferences":{"DailyMed":["phenylephrine%20hydrochloride"],"PubChem":["144204448","144208459","144213163","170465356","26751602","50106782","855560"],"chEBI":["8094"]},"count":11,"approvedIndications":["EFO_0007486"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0004610","EFO_0001059","EFO_0000178","EFO_0008521","EFO_0007486","EFO_0004269","EFO_0000544","EFO_0007533","EFO_0000319","EFO_0007214","EFO_0003956","MONDO_0024355"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and is indicated for sinusitis and has 10 investigational indications."}
{"id":"CHEMBL1200420","canonicalSmiles":"Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl","inchiKey":"PLYSCVSCYOQVRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIDAZOLAM HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL655","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Buccolam","Dormicum","Hypnovel","Midazolam hydrochloride","Midazolam hydrochloride preservative free","Midozalam hydrochloride","Rocam","Seizalam","Versed"],"synonyms":["Midazolam hydrochloride","Midazolam hydrochloride civ","RO 21-3981/003","RO-213981001","Ro-213981-003","SHP-615","SHP615"],"crossReferences":{"DailyMed":["midazolam%20hydrochloride"],"PubChem":["144206166","170465015","49731994"]},"count":7,"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000113327","ENSG00000151834","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0000616","EFO_0007623","MONDO_0002009","EFO_1001454","Orphanet_3389","EFO_1001884","EFO_0000274","EFO_0000618","EFO_0009267","EFO_0000662","EFO_0000546","HP_0100543","HP_0002045","EFO_0007634"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200472","canonicalSmiles":"Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21","inchiKey":"IKMPWMZBZSAONZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUAZEPAM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doral"],"synonyms":["NSC-309702","Quazepam","Quazepam civ","SCH 16134","SCH-16134"],"crossReferences":{"DailyMed":["quazepam"],"Wikipedia":["Quazepam"],"drugbank":["DB01589"],"chEBI":["8694"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200506","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO","inchiKey":"NNRXCKZMQLFUPL-WBMZRJHASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHROMYCIN LACTOBIONATE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL532","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erythrocin","Erythromycin","Erythromycin lactobionate"],"synonyms":["Erythromycin lactobionate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 2 investigational indications."}
{"id":"CHEMBL1200589","canonicalSmiles":"CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1.Cl","inchiKey":"SVSFIELZISOJDT-XRZFDKQNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTIAM HYDROCHLORIDE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1296","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceradon","Pansporin"],"synonyms":["ABBOTT-48999","CGP-14221/E","Cefotiam hexetil hydrochloride","Cefotiam hydrochloride","SCE 963","SCE-963"],"crossReferences":{"PubChem":["144204281","170465103","56463238"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988."}
{"id":"CHEMBL1200590","canonicalSmiles":"Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1.Cl.O","inchiKey":"BAAVORPTHSKWGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLIZINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1623","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Antivert","Meclizine HCl"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200830","drugType":"Small molecule","blackBoxWarning":true,"name":"FERROUS SULFATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Feosol","Feospan","Fer-In-Sol","Fero-gradumet","Ferr sulf, dried","Ferrograd","Mol-iron","Monsels Solution","Natabec","Slow-fe"],"synonyms":["Ferrous sulfate","Ferrous sulfate heptahydrate","Ferrous sulfate hydrate","NSC-146177","NSC-57631"],"crossReferences":{"DrugCentral":["4528"],"PubChem":["144209778"],"Wikipedia":["Iron(II)_sulfate"],"chEBI":["75832"]},"count":6,"approvedIndications":["EFO_0004272"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for anemia (phenotype) and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200856","canonicalSmiles":"CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)/C=C\\C(=O)O","inchiKey":"FBZFLZSBKWFFRD-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIETHYLPERAZINE MALEATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1378","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Torecan"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200994","drugType":"Small molecule","blackBoxWarning":false,"name":"GALLIUM CITRATE GA 67","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110553","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gallium citrate ga 67","Neoscan"],"synonyms":["67ga","Gallium (67 ga)","Gallium (67 ga) citrate","Gallium (67ga) citrate","Gallium Citrate (67Ga)","Gallium citrate ga 67","Gallium citrate ga-67"],"crossReferences":{"DrugCentral":["4560"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976 and has 1 investigational indication."}
{"id":"CHEMBL1201003","canonicalSmiles":"Br.CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12","inchiKey":"UTINOWOSWSPFLJ-FSRHSHDFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELETRIPTAN HYDROBROMIDE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1510","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Relpax"],"synonyms":["Eletriptan hydrobromide","UK-116,044-04","UK-116044-04"],"crossReferences":{"DailyMed":["eletriptan%20hydrobromide"],"chEBI":["61176"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2002."}
{"id":"CHEMBL1201102","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21.Cl","inchiKey":"FTNWXGFYRHWUKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIFLUPROMAZINE HYDROCHLORIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL570","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vesprin"],"synonyms":["Triflupromazine hydrochloride"],"crossReferences":{"PubChem":["144204828","170465325","26747673","26747674","50107065","50107066","50107067","540840","541291","56422371","57288079","855673"],"chEBI":["9712"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957."}
{"id":"CHEMBL1201109","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"WBGKWQHBNHJJPZ-LECWWXJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESONIDE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desonate","Desonide","Desowen","Tridesilon","Verdeso"],"synonyms":["D-2083","D2083","Desonate","Desonide"],"crossReferences":{"DailyMed":["desonide"],"PubChem":["144206156","170464832"],"Wikipedia":["Desonide"],"drugbank":["DB01260"],"chEBI":["204734"]},"count":2,"approvedIndications":["EFO_0000274","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000676","EFO_0000274","EFO_0005752"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for eye inflammation and atopic eczema."}
{"id":"CHEMBL1201110","canonicalSmiles":"CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21.Cl","inchiKey":"ZCDDBUOENGJMLV-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALACYCLOVIR HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1349","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Valacyclovir hydrochloride","Valtrex"],"synonyms":["256-U-87 HYDROCHLORIDE","256U87 HYDROCHLORIDE","BW-256","BW-256U87","Valaciclovir hydrochloride","Valacyclovir hydrochloride"],"crossReferences":{"DailyMed":["valacyclovir%20hydrochloride"],"PubChem":["144205291","170465373","49681602"],"chEBI":["9919"]},"count":9,"approvedIndications":["EFO_1001347","EFO_0007282","EFO_0006510","EFO_0007204"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 4 approved and 5 investigational indications."}
{"id":"CHEMBL1201111","canonicalSmiles":"Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O.Cl","inchiKey":"MKBLHFILKIKSQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONDANSETRON HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL46","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ondansetron HCl","Zofran"],"synonyms":["GR-38032F"],"crossReferences":{"PubChem":["49681594"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201163","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"OJCZPLDERGDQRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUFENTANIL CITRATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL658","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dsuvia","Sufenta","Sufenta preservative free","Sufental","Sufentanil citrate"],"synonyms":["R 33800","R-33800","Sufentanil citrate","Sufentanil citrate cii"],"crossReferences":{"DailyMed":["sufentanil%20citrate"],"PubChem":["144206432","85273816"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201165","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC5CCCC5)ccc4[C@H]3CC[C@@]21C","inchiKey":"PWZUUYSISTUNDW-VAFBSOEGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINESTROL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estrovis"],"synonyms":["Quinestrol","W 3566","W-3566"],"crossReferences":{"PubChem":["11532988","144205893","170465054","29217904","56422146"],"Wikipedia":["Quinestrol"],"drugbank":["DB04575"],"chEBI":["8716"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201270","canonicalSmiles":"C1N2CN3CN1CN(C2)C3","inchiKey":"VKYKSIONXSXAKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHENAMINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uritone","Urotropin"],"synonyms":["E-239","E239","Hexamethylenamine","Hexamethylenetetramine","Hexamine","INS NO.239","INS-239","Methenamine","NSC-26346","NSC-403347"],"crossReferences":{"DailyMed":["methenamine%20hippurate"],"PubChem":["144207004","144208804","144210820","170465468","57260105"],"Wikipedia":["Hexamethylenetetramine"],"drugbank":["DB06799"],"chEBI":["6824"]},"childChemblIds":["CHEMBL1201104","CHEMBL3833312","CHEMBL3707448"],"count":3,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL1201281","canonicalSmiles":"O=C(O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1","inchiKey":"LIRCDOVJWUGTMW-ZWNOBZJWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORAMPHENICOL SUCCINIC ACID","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chloramphenicol succinate"],"crossReferences":{"DailyMed":["chloramphenicol%20sodium%20succinate"],"drugbank":["DB07565"]},"childChemblIds":["CHEMBL1200729"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201349","canonicalSmiles":"C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21","inchiKey":"HDZAQYPYABGTCL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAFLUORENIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hexafluorenium","Hexafluronium"],"crossReferences":{"drugbank":["DB00941"]},"childChemblIds":["CHEMBL1200933"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201776","canonicalSmiles":"CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C","inchiKey":"KWTWDQCKEHXFFR-SMDDNHRTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TAPENTADOL","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BN 200 (BASE)","BN-200","CG-5503","CG5503","CG5503 (BASE)","CG5503 IR","Tapentadol"],"crossReferences":{"DailyMed":["tapentadol%20hydrochloride"],"Wikipedia":["Tapentadol"],"drugbank":["DB06204"]},"childChemblIds":["CHEMBL1201777"],"count":11,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000616","MONDO_0001583","HP_0012532","HP_0003418","EFO_0003843","EFO_1000783","HP_0005184","EFO_0002506","EFO_0003100","EFO_1000786","EFO_0004616","HP_0003419","EFO_1000999","HP_0001822"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for pain and has 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213446","canonicalSmiles":"O=c1c2c3c(sc2ncn1Cc1nnn[nH]1)CCCC3","inchiKey":"QSBQXAOOVSQABJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213446","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06889"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL122","canonicalSmiles":"CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1","inchiKey":"RZJQGNCSTQAWON-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROFECOXIB","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"," Neurotoxicity"],"year":2004},"tradeNames":["Vioxx"],"synonyms":["M01AH02","MK-0966","MK-966","MK0966","Rofecoxib","TRM-201"],"crossReferences":{"PubChem":["144204983","174007305","26748942","49665949","535364"],"Wikipedia":["Rofecoxib"],"drugbank":["DB00533"],"chEBI":["8887"]},"childChemblIds":["CHEMBL4465601"],"count":12,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0003897","EFO_0000280","EFO_0000685","EFO_0000249","EFO_0005406","EFO_0003843","EFO_0005755","MONDO_0008315","EFO_0003060","EFO_1001951","MONDO_0000147","EFO_0002506","Orphanet_733","EFO_0004616","EFO_0000326","EFO_0003833"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for rheumatic disease and has 11 investigational indications. It was withdrawn in United States  in 2004 due to Cardiotoxicity and  Neurotoxicity."}
{"id":"CHEMBL1231178","canonicalSmiles":"O=[N+]([O-])c1ccc(OP(=O)(O)Oc2ccc([N+](=O)[O-])cc2)cc1","inchiKey":"MHSVUSZEHNVFKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231178","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["89855347"],"drugbank":["DB07418"],"chEBI":["3122"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233274","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC(=O)O","inchiKey":"YJPIDPAGJSWWBE-FNIAAEIWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233274","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56423683","855719"],"drugbank":["DB07891"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233349","canonicalSmiles":"OCC1=C[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"PJPGMULJEYSZBS-VZFHVOOUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Streptol"],"crossReferences":{"Wikipedia":["Valienol"],"drugbank":["DB03092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234133","canonicalSmiles":"COc1cccc(OC)c1-c1cc2cnc(N)nc2nc1N","inchiKey":"LRPHIAJXODIASX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234133","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08145"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234443","canonicalSmiles":"O=S(=O)(O)CCCN1CCOCC1","inchiKey":"DVLFYONBTKHTER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234443","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212463"],"drugbank":["DB03434"],"chEBI":["44115"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234797","canonicalSmiles":"NCCCNc1ccccc1[N+](=O)[O-]","inchiKey":"GVGDDEYVTBKACE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234797","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08291"]},"childChemblIds":["CHEMBL3221533"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236594","canonicalSmiles":"COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O","inchiKey":"SOECUQMRSRVZQQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Coenzyme Q1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ubiquinone-1"],"crossReferences":{"drugbank":["DB08689"],"chEBI":["46234"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1238","canonicalSmiles":"O=C(O)CCCCCCCC(=O)O","inchiKey":"BDJRBEYXGGNYIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELAIC ACID","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azelex","Finacea","Skinoren"],"synonyms":["Azelaic acid","NSC-19493","ZK 62498","ZK-62498"],"crossReferences":{"DailyMed":["azelaic%20acid"],"PubChem":["11110663","144209187","144213328","170465358","50105776","56422409","8139926","85230873","90341560"],"Wikipedia":["Azelaic_acid"],"drugbank":["DB00548"],"chEBI":["48131"]},"count":4,"approvedIndications":["EFO_1000760","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for rosacea and acne and has 2 investigational indications."}
{"id":"CHEMBL124162","canonicalSmiles":"CCC(=O)O[C@]1(CC)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1","inchiKey":"YCNIQYLWIPCLNY-QHCPKHFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMPTOTHECIN-20-O-PROPIONATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Camptothecin-20-o-propionate"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1256674","canonicalSmiles":"C1COC(NC(C2CC2)C2CC2)=N1.O=C(O)/C=C/C(=O)O","inchiKey":"VCWFVUAJSIPMTF-WLHGVMLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILMENIDINE HEMIFUMARATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL289480","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rilmenidine Hemifumarate"],"crossReferences":{"PubChem":["855605"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1275802","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)CC)C(C)C","inchiKey":"KGZGFSNZWHMDGZ-KAYYGGFYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PEXIGANAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pexiganan"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1346","canonicalSmiles":"NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1","inchiKey":"HXGBXQDTNZMWGS-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARIFENACIN","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Darifenacin","Enablex","UK-88525"],"crossReferences":{"DailyMed":["darifenacin%20hydrobromide"],"PubChem":["50113277"],"Wikipedia":["Darifenacin"],"drugbank":["DB00496"],"chEBI":["391960"]},"childChemblIds":["CHEMBL1200935"],"count":3,"approvedIndications":["HP_0000020","HP_0000103"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["HP_0000020","EFO_1000781","HP_0000103"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for urinary incontinence and polyuria and has 1 investigational indication."}
{"id":"CHEMBL1347191","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC.Cl.O","inchiKey":"BZVASJSWLMETJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1347191","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26719741","49681656"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1349073","canonicalSmiles":"CCOC(=O)COc1ccc2c(=O)cc(-c3ccccc3)oc2c1","inchiKey":"ZVXBAHLOGZCFTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFLOXATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efloxate"],"crossReferences":{"PubChem":["124894102","124894103","144206728","144206729","26729810"],"drugbank":["DB13333"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL139877","canonicalSmiles":"NC(=O)NS(=O)(=O)c1ccc(N)cc1","inchiKey":"WVAKABMNNSMCDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACARBAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Dermatological toxicity"," Hematological toxicity"," Hepatotoxicity"],"year":1988},"tradeNames":["Uromide"],"synonyms":["Sulfacarbamide","Sulphaurea"],"crossReferences":{"PubChem":["144205723","170466277"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1988 due to Dermatological toxicity,  Hematological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL1483","canonicalSmiles":"CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1","inchiKey":"HXHWSAZORRCQMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBENDAZOLE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Albenza","Eskazole","Valbazen","Zental","Zentel"],"synonyms":["Albendazole","NSC-220008","SK&F 62979","SK&F-62979"],"crossReferences":{"DailyMed":["albendazole"],"PubChem":["11112790","124882630","124882632","144204210","144212617","170464897","26746999","855809"],"Wikipedia":["Albendazole"],"drugbank":["DB00518"],"chEBI":["16664"]},"count":12,"approvedIndications":["EFO_1001342","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for helminthiasis and infection and has 10 investigational indications."}
{"id":"CHEMBL149603","canonicalSmiles":"N#Cc1ccc2cccc(OP(=O)(O)O)c2n1","inchiKey":"NQLPTOOPFMPCHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL149603","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02762"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1512949","canonicalSmiles":"O=C(CN1CCN(Cc2ccc3c(c2)OCO3)CC1)N1c2ccccc2Sc2ccccc21","inchiKey":"UBAJTZKNDCEGKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOVERINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenoverine"],"crossReferences":{"PubChem":["144205534","170466194","29216372"],"drugbank":["DB13042"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1530287","canonicalSmiles":"CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.Cl","inchiKey":"KXPXJGYSEPEXMF-MOUKNHLCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1530287","maximumClinicalTrialPhase":0,"parentId":"CHEMBL569713","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11533055","144212543","56422902"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1559","canonicalSmiles":"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O","inchiKey":"MCCACAIVAXEFAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MICONAZOLE NITRATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL91","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acorvio","Daktarin aktiv","Dermonistat","Femeron","Gyno-daktarin","M-zole 3 combination pack","M-zole 7 dual pack","Miconazole 3","Miconazole 3 combination pack","Miconazole 7","Miconazole 7 combination pack","Miconazole nitrate","Miconazole nitrate combination pack","Monistat","Monistat 1 combination pack","Monistat 3","Monistat 3 combination pack","Monistat 3 combination pack (prefilled)","Monistat 5","Monistat 7","Monistat 7 combination pack","Monistat-3 Combination Pack","Monistat-derm"],"synonyms":["Miconazole nitrate","NSC-169434","R 14,889","R-14889"],"crossReferences":{"DailyMed":["miconazole%20nitrate"],"PubChem":["26748144","562772","56422501","855623"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and has 1 investigational indication."}
{"id":"CHEMBL157548","canonicalSmiles":"CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1","inchiKey":"QMLVECGLEOSESV-RYUDHWBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANOFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danofloxacin"],"crossReferences":{"PubChem":["144205730","170466637","26757967"],"Wikipedia":["Danofloxacin"],"drugbank":["DB11393"]},"childChemblIds":["CHEMBL2106153"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1593566","canonicalSmiles":"CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)c1cccc(Oc2ccccc2)c1","inchiKey":"OWZREIFADZCYQD-NSHGMRRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELTAMETHRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decamethrin","Deltamethrin"],"crossReferences":{"PubChem":["144208630","144213326","26757319","29216447"],"Wikipedia":["Deltamethrin"],"drugbank":["DB13600"],"chEBI":["4388"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL159776","canonicalSmiles":"CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C","inchiKey":"ZULJGOSFKWFVRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMIRACETAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pramiracetam"],"crossReferences":{"PubChem":["174006794"],"Wikipedia":["Pramiracetam"],"drugbank":["DB13247"]},"childChemblIds":["CHEMBL2106874","CHEMBL2105204"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL16073","canonicalSmiles":"CCOc1ccc(NC(C)=O)cc1","inchiKey":"CPJSUEIXXCENMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENACETIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"," Denmark"],"classes":["Nephrotoxicity"],"year":1980},"tradeNames":[],"synonyms":["Acetophenetidin","Acetphenetidin","Phenacetin"],"crossReferences":{"PubChem":["11112166","124882016","144203898","144209124","144213212","170465554","17389770","26747350","26752987","50086861"],"TG-GATEs":["138"],"Wikipedia":["Phenacetin"],"drugbank":["DB03783"],"chEBI":["8050"]},"childChemblIds":["CHEMBL461346"],"count":2,"approvedIndications":["HP_0001945","EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever. It was withdrawn in United Kingdom,  United States,  Germany and  Denmark initially in 1980 due to Nephrotoxicity."}
{"id":"CHEMBL1615933","canonicalSmiles":"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O","inchiKey":"MVPAMLBUDIFYGK-BHDRXCTLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OMIGANAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omiganan"],"crossReferences":{"drugbank":["DB06610"]},"childChemblIds":["CHEMBL1793889"],"count":7,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1644698","canonicalSmiles":"O=[N+]([O-])[O-].[Na+]","inchiKey":"VWDWKYIASSYTQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM NITRATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-251","E251","INS NO.251","INS-251","NSC-77390","Sodium nitrate"],"crossReferences":{"PubChem":["144209793"],"Wikipedia":["Sodium_nitrate"],"chEBI":["63005"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1736587","canonicalSmiles":"CC(=O)OCC[N+](C)(C)C.[O-][Cl+3]([O-])([O-])[O-]","inchiKey":"SHIQLFRCVFUYEK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1736587","maximumClinicalTrialPhase":0,"parentId":"CHEMBL667","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56320703"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1738","canonicalSmiles":"C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1","inchiKey":"BMKDZUISNHGIBY-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXRAZOXANE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardioxane","Zinecard"],"synonyms":["ADR-529","Dexrazoxane","ICRF-187","NSC-169780"],"crossReferences":{"DailyMed":["dexrazoxane%20hydrochloride"],"PubChem":["144205809","170464709","442425"],"Wikipedia":["Dexrazoxane"],"drugbank":["DB00380"],"chEBI":["50223"]},"childChemblIds":["CHEMBL1200778"],"count":13,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 13 investigational indications."}
{"id":"CHEMBL1741134","canonicalSmiles":"O=S(=O)(O)Oc1ccc(C(c2ccc(OS(=O)(=O)O)cc2)c2ccccn2)cc1","inchiKey":"UJIDKYTZIQTXPM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICOSULFURIC ACID","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["sodium%20picosulfate"],"drugbank":["DB09268"]},"childChemblIds":["CHEMBL1697768"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012."}
{"id":"CHEMBL1743011","drugType":"Antibody","blackBoxWarning":false,"name":"ENAVATUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enavatuzumab","PDL 192","PDL-192"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743033","drugType":"Antibody","blackBoxWarning":false,"name":"ITOLIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMAB-600","EQ001","Itolizumab"],"count":2,"linkedTargets":{"rows":["ENSG00000013725"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0000270","EFO_0004599"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743064","drugType":"Antibody","blackBoxWarning":false,"name":"ROBATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["19D12","Robatumumab","SCH 717454","SCH-717454"],"count":2,"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001951"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1788388","canonicalSmiles":"CCCCOC(=O)CCC(=O)OCCCC","inchiKey":"YUXIBTJKHLUKBD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIBUTYLSUCCINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibutylsuccinate"],"crossReferences":{"PubChem":["144211831"],"drugbank":["DB13332"],"chEBI":["82263"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1801250","canonicalSmiles":"O=C(NO)c1cnc(N2C[C@H]3[C@H](NCc4ccc5cc(F)ccc5n4)[C@H]3C2)nc1","inchiKey":"QRGHOAATPOLDPF-VQFNDLOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NANATINOSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHR-3996","Chr 3996","Nanatinostat","VRX-3996"],"crossReferences":{"drugbank":["DB15419"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1823681","canonicalSmiles":"CCOC(=O)[C@@H](N)Cc1ccc(O)c(O)c1","inchiKey":"NULMGOSOSZBEQL-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETILEVODOPA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etilevodopa","TV-1203"],"crossReferences":{"drugbank":["DB06535"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1887585","canonicalSmiles":"[Na+].[O-][Cl+][O-]","inchiKey":"UKLNMMHNWFDKNT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1887585","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1906899","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144213117","17389734"],"drugbank":["DB13210"],"chEBI":["78667"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL188952","canonicalSmiles":"CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1","inchiKey":"PIDSZXPFGCURGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRPROFEN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," Germany"," France"],"classes":["Gastrotoxicity"," Hepatotoxicity"],"year":1990},"tradeNames":[],"synonyms":["Pirprofen","SU 21524"],"crossReferences":{"Wikipedia":["Pirprofen"],"drugbank":["DB13722"]},"count":1,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and is indicated for rheumatic disease. It was withdrawn in Spain,  Germany and  France initially in 1990 due to Gastrotoxicity and  Hepatotoxicity."}
{"id":"CHEMBL191083","canonicalSmiles":"CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1","inchiKey":"RBTBFTRPCNLSDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHYLENE BLUE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DNDI1417128"],"crossReferences":{"DailyMed":["methylene%20blue"],"PubChem":["124893332","29215388","50112749"],"drugbank":["DB08167"],"chEBI":["43830"]},"childChemblIds":["CHEMBL405110","CHEMBL550495"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2016. This drug has a black box warning from the FDA."}
{"id":"CHEMBL206468","canonicalSmiles":"OC[C@H]1CNC[C@@H](O)[C@@H]1O","inchiKey":"QPYJXFZUIJOGNX-HSUXUTPPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFEGOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afegostat","Isofagomine"],"crossReferences":{"PubChem":["85267413"],"drugbank":["DB04545"]},"childChemblIds":["CHEMBL2105671"],"linkedTargets":{"rows":["ENSG00000177628"],"count":1},"linkedDiseases":{"rows":["Orphanet_355"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL207602","canonicalSmiles":"CCCCCCCCCCCCCC(=O)OC(C)C","inchiKey":"AXISYYRBXTVTFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROPYL MYRISTATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Estergel"],"synonyms":["Isopropyl myristate"],"crossReferences":{"PubChem":["144205633","144209263","144213488","170465683","26757488"],"drugbank":["DB13966"],"chEBI":["90027"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL20883","canonicalSmiles":"O=c1[nH]c(=O)n(C2CCCO2)cc1F","inchiKey":"WFWLQNSHRPWKFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGAFUR","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Citofur","Uftoral"],"synonyms":["FT-207","MJF-12264","NSC-148958","Tegafur"],"crossReferences":{"PubChem":["144205202","144212129","170465809","26754499","29215356","56422217","8139878"],"Wikipedia":["Tegafur"],"drugbank":["DB09256"],"chEBI":["32188"]},"count":37,"approvedIndications":["EFO_0000616","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cancer and neoplasm and has 35 investigational indications."}
{"id":"CHEMBL20945","canonicalSmiles":"O=[N+]([O-])c1cccc(B(O)O)c1","inchiKey":"ZNRGSYUVFVNSAW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Nitrophenyl Boronic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Nitrophenyl Boronic Acid","3-Nitrophenylboronic Acid","M-Nitophenyl Boronic Acid"],"crossReferences":{"PubChem":["26753147"],"drugbank":["DB02797"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103849","canonicalSmiles":"CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1","inchiKey":"IYFNEFQTYQPVOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UDENAFIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA-8159","Udenafil"],"crossReferences":{"drugbank":["DB06267"]},"count":9,"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0003777","EFO_0004718","EFO_0004234","EFO_0000249","EFO_0001421","EFO_1000657","EFO_1001207","MONDO_0008315","EFO_1001145","EFO_1000899"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2103995","canonicalSmiles":"C=CCC1CN(C)CCC1(OC(=O)CC)c1ccccc1","inchiKey":"KGYFOSCXVAXULR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLYLPRODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allylprodine"],"crossReferences":{"drugbank":["DB01542"]},"childChemblIds":["CHEMBL3246685"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104217","canonicalSmiles":"O=C([O-])[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)[O-].[Ca+2]","inchiKey":"UGZVNIRNPPEDHM-SBBOJQDXSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM SACCHARATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium saccharate"],"crossReferences":{"drugbank":["DB13962"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104607","canonicalSmiles":"CCN(CC)C(=O)c1cccnc1","inchiKey":"NCYVXEGFNDZQCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIKETHAMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Multiple unspecified markets"],"classes":["Neurotoxicity"],"year":1988},"tradeNames":["Coramine","Nikethyl"],"synonyms":["Nicethamide","Nikethamide"],"crossReferences":{"PubChem":["225144265"],"drugbank":["DB13655"]},"count":1,"approvedIndications":["EFO_0000684"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for respiratory system disease. It was withdrawn in Multiple unspecified markets  in 1988 due to Neurotoxicity."}
{"id":"CHEMBL2104954","canonicalSmiles":"COc1cc2c(Nc3ccc(Sc4nccn4C)c(Cl)c3)c(C#N)cnc2cc1N1CCC(N2CCCC2)CC1","inchiKey":"CVAKNHIXTWLGJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALAMAPIMOD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balamapimod","MKI-833"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105684","canonicalSmiles":"Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21.O=S(=O)(O)O","inchiKey":"GRKFGZYYYYISDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELUMETINIB SULFATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1614701","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Koselugo"],"synonyms":["AZD-6244 HYD-SULFATE","AZD-6244 HYDROGEN SULFATE","AZD6244 HYD-SULFATE","AZD6244 HYDROGEN SULFATE","Selumetinib sulfate"],"crossReferences":{"DailyMed":["selumetinib%20sulfate"]},"count":5,"approvedIndications":["Orphanet_636"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for neurofibromatosis type 1 and has 4 investigational indications."}
{"id":"CHEMBL2105719","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O","inchiKey":"BSPLGGCPNTZPIH-IPZCTEOASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DACOMITINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110732","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vizimpro"],"synonyms":["Dacomitinib","PF-00299804-03","Pf-00299804"],"crossReferences":{"DailyMed":["dacomitinib"]},"count":1,"approvedIndications":["EFO_0003060"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000178568","ENSG00000141736"],"count":3},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for non-small cell lung carcinoma."}
{"id":"CHEMBL2105829","canonicalSmiles":"CCOC(=O)C1=C(c2ccc(-n3c(C)nc4cnccc43)cc2)NC(C)=C(C(=O)Nc2ccccn2)[C@H]1c1ccccc1Cl","inchiKey":"ODRYSCQFUGFOSU-SSEXGKCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MODIPAFANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Modipafant","UK-80067"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106011","canonicalSmiles":"CC(=O)OCC(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C","inchiKey":"ARPLCFGLEYFDCN-CDACMRRYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOCORTOLONE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clocortolone","Clocortolone acetate","SH 818"],"crossReferences":{"drugbank":["DB14652"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106419","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(c2ccccc2)c2ccccc2)C1c1cccc([N+](=O)[O-])c1.Cl","inchiKey":"WMFYOYKPJLRMJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LERCANIDIPINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL250270","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardiovasc","Carmen","Corifeo","Lercadip","Lercan","Lercapin","Lercaton","Lerkamen","Lerzam","Renovia","Vasodip","Zandip","Zanicor","Zanidip"],"synonyms":["Lercanidipine hydrochloride","REC-15/2375"],"crossReferences":{"PubChem":["144206046","170465587"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2106526","canonicalSmiles":"CCN(C)C(C)C=C(c1cccs1)c1cccs1","inchiKey":"MORSAEFGQPDBKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLMETHYLTHIAMBUTENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethylmethylthiambutene"],"crossReferences":{"drugbank":["DB01468"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106573","canonicalSmiles":"CCN(CC)C(C)C=C(c1cccs1)c1cccs1","inchiKey":"CBYWMRHUUVRIAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLTHIAMBUTENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diethylthiambutene"],"crossReferences":{"drugbank":["DB01533"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107261","canonicalSmiles":"Cc1ccc(C(CCN(C)C)c2ccccc2)cc1","inchiKey":"CINROOONPHQHPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLPROPAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tolpropamine"],"crossReferences":{"drugbank":["DB13305"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107760","canonicalSmiles":"COc1ccccc1Oc1c(NS(=O)(=O)/C=C/c2ccccc2)nc(-c2ncccn2)nc1OC","inchiKey":"LONWRQOYFPYMQD-DTQAZKPQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBENTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HE-11","Nebentan","Ym598"],"count":2,"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["EFO_0000673","MONDO_0008315"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107762","canonicalSmiles":"CCCN(c1ccncc1F)n1cc(C)c2ccccc21","inchiKey":"BTDHTARYCBHHPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERISPIRDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HP184","Nerispirdine"],"crossReferences":{"drugbank":["DB12714"]},"childChemblIds":["CHEMBL3585642"],"count":2,"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000129159","ENSG00000168263","ENSG00000053918","ENSG00000140015","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000153253","ENSG00000111262","ENSG00000102057","ENSG00000136546","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000168356","ENSG00000177301","ENSG00000168418","ENSG00000158445","ENSG00000089558","ENSG00000135519","ENSG00000151079","ENSG00000144285","ENSG00000166006","ENSG00000169432","ENSG00000104848","ENSG00000156486","ENSG00000136531","ENSG00000184611","ENSG00000171385"],"count":50},"linkedDiseases":{"rows":["EFO_0003885","EFO_1001919"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107834","canonicalSmiles":"COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N","inchiKey":"WXXSNCNJFUAIDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RIOCIGUAT","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adempas","Bay 63-2521"],"synonyms":["BAY 63-2521","BAY-63-2521","Riociguat"],"crossReferences":{"DailyMed":["riociguat"],"drugbank":["DB08931"],"chEBI":["76018"]},"count":11,"approvedIndications":["MONDO_0005149","EFO_0001361","Orphanet_422","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000164116","ENSG00000061918","ENSG00000123201","ENSG00000152402"],"count":4},"linkedDiseases":{"rows":["Orphanet_797","MONDO_0005149","EFO_0001361","Orphanet_232","Orphanet_422","EFO_0000764","EFO_0001645","Orphanet_586","EFO_1001993","MONDO_0043839","EFO_0000717","EFO_1001145","EFO_0000537"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 4 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108165","drugType":"Unknown","blackBoxWarning":false,"name":"VALERIAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4M98M04Z3Z","7D1DL7VY9S","FEMA NO. 3099","FMM0HE453U","Powdered valerian extract","Valerian","Valeriana officinalis","Valeriana officinalis extract","Valeriana officinalis rhizome dry extract","Valeriana officinalis root","Valeriana officinalis root extract","Valeriana officinalis root tincture","Valeriana officinalis root with rhizome"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108556","drugType":"Protein","blackBoxWarning":false,"name":"PEXIGANAN ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cytolex"],"synonyms":["MSI-78","Pexiganan acetate"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108705","drugType":"Unknown","blackBoxWarning":false,"name":"ASTUPROTIMUT-R","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Astuprotimut-r","GSK-1572932A","GSK-249553","GSK1572932A","MAGE-A3","Mage a3 protein","Mage-a3 asci","SB-249553","Zastumotide"],"count":6,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109073","drugType":"Unknown","blackBoxWarning":false,"name":"HORSE CHESTNUT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aesculus hippocastanum","Aesculus hippocastanum dry extract","Aesculus hippocastanum extract","Aesculus hippocastanum fruit","Aesculus hippocastanum seed","Aesculus hippocastanum seed dry extract","Aesculus hippocastanum seed extract","Horse chestnut","Horse chestnut dried extract"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109307","drugType":"Antibody","blackBoxWarning":false,"name":"LMB-7","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LMB-7","Lmb-7"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109308","drugType":"Antibody","blackBoxWarning":false,"name":"ONCOLYSIN B","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONCOLYSIN B"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109418","drugType":"Antibody","blackBoxWarning":false,"name":"3F8","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3F8","3f8"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109420","drugType":"Antibody","blackBoxWarning":false,"name":"CH14.18","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CH14.18","Dinutuximab","Dinutuximab beta"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109487","drugType":"Antibody","blackBoxWarning":false,"name":"RG-1512","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-1512"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109527","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-578","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-578","Medi-578"],"count":2,"linkedTargets":{"rows":["ENSG00000134259"],"count":1},"linkedDiseases":{"rows":["EFO_0002506","EFO_0003843"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109587","drugType":"Antibody","blackBoxWarning":false,"name":"AZ9773","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-9773","AZ9773"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109626","drugType":"Antibody","blackBoxWarning":false,"name":"ALG-991","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALG-991","Alg-991"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2111176","canonicalSmiles":"CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1","inchiKey":"UPPMZCXMQRVMME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALETHAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Valethamate"],"crossReferences":{"drugbank":["DB13497"]},"childChemblIds":["CHEMBL2107687"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2130858","canonicalSmiles":"NC(=O)OCC(COC(N)=O)c1ccccc1.O","inchiKey":"SURCBXDHJRINFW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2130858","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1094","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49681633"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2131781","canonicalSmiles":"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)[C@H](O)[C@@H](O)C(=O)O","inchiKey":"CJMJLDQKTOJACI-BGQAIRJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2131781","maximumClinicalTrialPhase":0,"parentId":"CHEMBL442","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204734","144208903","144213499"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL216543","canonicalSmiles":"O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\\O","inchiKey":"HBDSHCUSXQATPO-BGBJRWHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL216543","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124880404","124880405","162108255","17405181","26752251","26752252","50104963","50104964","85231086","90340596"],"drugbank":["DB02052"],"chEBI":["43645"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2179582","canonicalSmiles":"CC1(C)C(=O)N(C(=O)NCC2CCN(CC3(O)CCOCC3)CC2)c2cc(F)ccc21","inchiKey":"AGMOFKKOVMRGAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03382792","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-03382792"],"crossReferences":{"drugbank":["DB12949"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218878","canonicalSmiles":"COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC.O=C(O)[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"DQOGWKZQQBYYMW-LQGIGNHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETREXATE GLUCURONATE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL119","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neutrexin"],"synonyms":["Trimetrexate d-glucuronate","Trimetrexate glucuronate"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 4 investigational indications."}
{"id":"CHEMBL2251240","canonicalSmiles":"Br.CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.O.O.O","inchiKey":"LACQPOBCQQPVIT-SEYKEWMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCOPOLAMINE HYDROBROMIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL569713","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isopto hyoscine","Joy-rides","Kwells","Kwells kids","Scopoderm","Scopoderm tts","Transcop","Transderm-scop"],"synonyms":["Hyoscine","Hyoscine hydrobromide","Hyoscine hydrobromide trihydrate","NSC-61806","Scopolamine hydrobromide","Scopolamine hydrobromide hydrate","Scopolamine hydrobromide trihydrate"],"crossReferences":{"PubChem":["144204730","144208065"],"chEBI":["61272"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL228133","canonicalSmiles":"Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1","inchiKey":"HPWBHQIUIBFTQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL228133","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23393","canonicalSmiles":"CCCCCCCCCCCCOS(=O)(=O)[O-].[Na+]","inchiKey":"DBMJMQXJHONAFJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM LAURYL SULFATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E487","NSC-402488","Sodium lauryl sulfate"],"crossReferences":{"DrugCentral":["4144"],"PubChem":["144204610","144208812","144210469","170465474","17388729","17388731","26752879"],"Wikipedia":["Sodium_dodecyl_sulfate"],"drugbank":["DB00815"],"chEBI":["8984"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2360839","canonicalSmiles":"CC(=O)O.N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"ZHFGXNMADRRGQP-HPILINOVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL2360839","maximumClinicalTrialPhase":0,"parentId":"CHEMBL373742","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205956"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364618","canonicalSmiles":"CC(C)(O)c1ccccc1-c1ccc2[nH]c(/C=C/c3ccc(C(F)(F)F)cc3)nc2c1","inchiKey":"ORDHXXHTBUZRCN-NTEUORMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAVATREP","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-39439335","Mavatrep"],"crossReferences":{"drugbank":["DB12875"]},"count":1,"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["EFO_0004616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2377051","canonicalSmiles":"[2H]C1([2H])C[C@@H]2[C@H](O1)OC([2H])([2H])[C@]2([2H])OC(=O)N[C@@H](Cc1ccc(OC([2H])([2H])c2csc(C)n2)cc1)[C@]([2H])(O)CN(C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])S(=O)(=O)c1ccc2c(c1)OC([2H])([2H])O2","inchiKey":"JORVRJNILJXMMG-KUHUZKIYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2377051","maximumClinicalTrialPhase":0,"parentId":"CHEMBL206031","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL248594","canonicalSmiles":"CCCCC1OC(=O)c2ccccc21","inchiKey":"HJXMNVQARNZTEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAC-3-N-BUTYLPHTHALIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Butylphthalide","Rac-3-n-butylphthalide"],"crossReferences":{"drugbank":["DB12749"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL252557","canonicalSmiles":"O=C(O)CO","inchiKey":"AEMRFAOFKBGASW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCOLIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Hydroxyacetic Acid","Glycolic acid","NSC-166"],"crossReferences":{"PubChem":["144211615","29216299"],"Wikipedia":["Glycolic_acid"],"drugbank":["DB03085"],"chEBI":["17497"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL288441","canonicalSmiles":"COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl","inchiKey":"UBPYILGKFZZVDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOSUTINIB","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bosulif"],"synonyms":["Bosutinib","Bosutinib monohydrate","SK-606","SKI-606"],"crossReferences":{"DailyMed":["bosutinib%20monohydrate"],"PubChem":["124950167"],"Wikipedia":["Bosutinib"],"drugbank":["DB06616"],"chEBI":["39112"]},"childChemblIds":["CHEMBL2131134"],"count":19,"approvedIndications":["EFO_0000616","EFO_0000339"],"linkedTargets":{"rows":["ENSG00000101336","ENSG00000097007","ENSG00000254087","ENSG00000197122"],"count":4},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0000220","HP_0000726","MONDO_0008170","MONDO_0007254","EFO_1000131","EFO_0000222","MONDO_0002087","EFO_1001496","EFO_0000305","EFO_0003060","MONDO_0001187","EFO_0000565","MONDO_0002586","EFO_1000581","EFO_0000339","EFO_0000588","MONDO_0002974","EFO_0000519"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for neoplasm and chronic myelogenous leukemia and has 17 investigational indications."}
{"id":"CHEMBL290916","canonicalSmiles":"CC1=NN(c2ccccc2)C(=O)C1","inchiKey":"QELUYTUMUWHWMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EDARAVONE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Radicava","Radicut"],"synonyms":["Antipyrine related compound a","Edaravone","MCI-186","NSC-12","NSC-26139","NSC-2629","Norphenazone","Radicut"],"crossReferences":{"DailyMed":["edaravone"],"PubChem":["11113339","124883490","144205630","144208945","144213136","170465935","17389763","26746991","26751506","26757432","56422481","855774"],"Wikipedia":["Edaravone"],"drugbank":["DB12243"],"chEBI":["31530"]},"count":5,"approvedIndications":["EFO_0000253"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for amyotrophic lateral sclerosis and has 4 investigational indications."}
{"id":"CHEMBL299001","canonicalSmiles":"Cc1cc(C)cc(S(=O)(=O)c2cccc(N)c2C#N)c1","inchiKey":"SWGDXLAZBZDUBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL299001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08528"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039538","drugType":"Protein","blackBoxWarning":false,"name":"TRENONACOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ixinity[tm]"],"synonyms":["IB-1001","IB1001","Trenonacog alfa"],"count":4,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL312040","canonicalSmiles":"CCOc1ccc(Cc2nc3cc([N+](=O)[O-])ccc3n2CCN(CC)CC)cc1","inchiKey":"PXDBZSCGSQSKST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETONITAZENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BA-20684","Etobedolum","Etonitazene","NIH 7607"],"crossReferences":{"PubChem":["144206383"],"Wikipedia":["Etonitazene"],"drugbank":["DB01462"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183293","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O.Cl","inchiKey":"LSLQGMMMRMDXHN-GEUPQXMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183293","maximumClinicalTrialPhase":0,"parentId":"CHEMBL317094","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206354","170466024"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184685","canonicalSmiles":"CCCCC(CC)COC(=O)c1ccccc1","inchiKey":"UADWUILHKRXHMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184685","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211793"],"drugbank":["DB11291"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184791","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"QTENRWWVYAAPBI-YCRXJPFRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"STREPTOMYCIN SULFATE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL372795","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Agri-Strep","Streptomycin sulfate","Streptorex","Vetstrep"],"synonyms":["Streptomycin sulfate"],"crossReferences":{"PubChem":["144205136"]},"count":6,"approvedIndications":["EFO_1001444","EFO_0003106","EFO_0007291","EFO_0003103","EFO_0007481","Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and has 6 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL323668","canonicalSmiles":"COc1cc2c(c(OC)c1OC)-c1ccc(=O)c(O)cc1C(NC(C)=O)CC2","inchiKey":"PRGILOMAMBLWNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL323668","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26749960","49670650"],"drugbank":["DB15534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL329592","canonicalSmiles":"CNC(C)C1CCC(N)C(OC2C(N)CC(N)C(OC3OCC(C)(O)C(NC)C3O)C2O)O1","inchiKey":"CEAZRRDELHUEMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL329592","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006261","174006636"],"drugbank":["DB00798"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL330498","canonicalSmiles":"COc1cc([C@H]2C3=C(COC3=O)Cc3cc4c(cc32)OCO4)cc(OC)c1OC","inchiKey":"OPGVEBTYBAOEHZ-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL330498","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15590"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3305985","canonicalSmiles":"C=CC[N@@+]12CC[C@@]34c5ccccc5N5/C=C6/[C@H]7C[C@H]8[C@@]9(CC[N@@+]8(CC=C)C/C7=C/CO)c7ccccc7N(/C=C(/[C@@H](C[C@@H]31)/C(=C\\CO)C2)[C@H]54)[C@@H]69","inchiKey":"MUQUYTSLDVKIOF-CHJKCJHBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCURONIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alcuronium"],"crossReferences":{"drugbank":["DB13648"],"chEBI":["55313"]},"childChemblIds":["CHEMBL3188339"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3306918","canonicalSmiles":"CC(C)n1c(=O)c(C(=O)NCCCN2CCCCC2)c(O)c2ccsc21","inchiKey":"SCHKZZSVELPJKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRX-03140","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prx-03140"],"crossReferences":{"drugbank":["DB05596"]},"childChemblIds":["CHEMBL3291085"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3318007","canonicalSmiles":"O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F","inchiKey":"JGPXDNKSIXAZEQ-SBBZOCNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMODIVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ - 63623872 - ZCD","JNJ-63623872","JNJ-63623872-ZCD","JNJ-872","JNJ63623872","JNJ872","Pimodivir","VX -787","VX-787"],"crossReferences":{"drugbank":["DB14974"]},"childChemblIds":["CHEMBL3989964"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3334567","canonicalSmiles":"C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21","inchiKey":"XYDNMOZJKOGZLS-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAVOLITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-6094","AZD6094","Azd-6094","HMPL-504","Savolitinib","Volitinib"],"crossReferences":{"drugbank":["DB12048"]},"count":12,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003863","EFO_0000640","MONDO_0001056","EFO_0000503","EFO_0000681","EFO_1000657","EFO_0000313","EFO_1000336","EFO_0003060","MONDO_0008315","EFO_1001951","EFO_1001949"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL3426917","canonicalSmiles":"[2H]C([2H])([2H])Oc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC([2H])([2H])[2H]","inchiKey":"SPMVMDHWKHCIDT-XERRXZQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3426917","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1289494","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3527027","canonicalSmiles":"C[C@H]1CNCCc2ccc(Cl)cc21.Cl.O","inchiKey":"NBENLXSMFWRJRU-JZGIKJSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3527027","maximumClinicalTrialPhase":0,"parentId":"CHEMBL360328","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544935","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-418","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["XL418","Xl-418"],"count":1,"linkedTargets":{"rows":["ENSG00000175634","ENSG00000105221","ENSG00000117020","ENSG00000108443","ENSG00000142208"],"count":5},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545006","drugType":"Small molecule","blackBoxWarning":false,"name":"PWT-33587","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pwt-33587"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545061","canonicalSmiles":"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C","inchiKey":"BROGCIMRGWLMOO-SJPGHYFNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FEXAPOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fexapotide","NX-1207","NYM-4805","NYM4805"],"childChemblIds":["CHEMBL3707309"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545124","canonicalSmiles":"CN(C)C(C(=O)Nc1ccc2c(=O)[nH]ccc2c1)c1ccsc1.Cl","inchiKey":"FUBBJNODZIIYHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VEROSUDIL HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545065","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-12286","Verosudil hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545187","canonicalSmiles":"O=C(/C=C\\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1ccccn1","inchiKey":"OPAKEJZFFCECPN-XQRVVYSFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERDINEXOR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KPT-335","Verdinexor"],"crossReferences":{"drugbank":["DB12207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545280","canonicalSmiles":"Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N","inchiKey":"JCYNMRJCUYVDBC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFATUTAZONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efatutazone"],"crossReferences":{"drugbank":["DB11894"]},"childChemblIds":["CHEMBL3545279"],"count":8,"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000365","MONDO_0002108","EFO_0001378","EFO_0003060","EFO_0000569","EFO_1001951","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545285","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-999","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["XL-999","Xl 999","Xl-999"],"count":7,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000066468","ENSG00000068078","ENSG00000102755","ENSG00000037280","ENSG00000160867","ENSG00000077782","ENSG00000157404","ENSG00000113721","ENSG00000122025"],"count":11},"linkedDiseases":{"rows":["MONDO_0008170","EFO_0000681","EFO_0000222","EFO_0001378","EFO_0003060","EFO_0000311","EFO_1001951"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3545318","drugType":"Cell","blackBoxWarning":false,"name":"REXLEMESTROCEL-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Neofuse","Revascor"],"synonyms":["Neofuse","Rexlemestrocel-l"],"count":1,"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545321","drugType":"Small molecule","blackBoxWarning":false,"name":"NMS-1116354","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nms-1116354"],"count":1,"linkedTargets":{"rows":["ENSG00000097046"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545348","drugType":"Protein","blackBoxWarning":false,"name":"BKT140","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4F-BENZOYL-TN-14003","BKT-140","BKT140","BL-8040","Bkt140","Bl 8040","Motixafortide","T140","TF 14016","TF-14016"],"count":11,"linkedTargets":{"rows":["ENSG00000121966"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0004251","EFO_1000044","MONDO_0000873","EFO_0000339","EFO_0002916","EFO_0000503","EFO_0000220","EFO_0000222","MONDO_0003219","EFO_0001378","EFO_0000183","HP_0001915"],"count":13},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL3545393","drugType":"Small molecule","blackBoxWarning":false,"name":"XL550","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-3150","Xl550"],"count":4,"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0000401","EFO_1002032","EFO_0000537","MONDO_0001422"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL358040","canonicalSmiles":"NCC(O)c1cccc(O)c1","inchiKey":"LRCXRAABFLIVAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORFENEFRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norfenefrine","Norfenefrine hydrochloride","WV 569 [AS HYDROCHLORIDE]"],"crossReferences":{"PubChem":["50112807"],"Wikipedia":["Norfenefrine"],"drugbank":["DB13378"]},"childChemblIds":["CHEMBL446333"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3581647","canonicalSmiles":"Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n1-2","inchiKey":"GNMUEVRJHCWKTO-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIRABRESIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Birabresib","MK-8628","OTX-015","OTX-015 ANHYDROUS","OTX015","OTX015 ANHYDROUS"],"crossReferences":{"drugbank":["DB15189"]},"count":6,"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0005783","EFO_0002517","MONDO_0007254","EFO_0000222","EFO_0000519","EFO_0003060","MONDO_0008315"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL359020","canonicalSmiles":"O=C(Nc1cc([C@@H]2CCCN2)[nH]n1)Nc1cccc2c1[C@@H]1CCCN1C2=O","inchiKey":"IWOOJEZSDPRYAZ-WFASDCNBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL359020","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06976"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL359965","canonicalSmiles":"C=CCS[S+]([O-])CC=C","inchiKey":"JDLKFOPOAOFWQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allicin","Diallyl Thiosulfinate"],"crossReferences":{"Wikipedia":["Allicin"],"drugbank":["DB11780"],"chEBI":["28411"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3600873","canonicalSmiles":"O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1","inchiKey":"LCVIRAZGMYMNNT-VVONHTQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3600873","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12556"]},"childChemblIds":["CHEMBL3951333"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3608680","canonicalSmiles":"Cc1nsc(-c2nnc3n2CCN(C(=O)c2ccc(F)cc2)[C@@H]3C)n1","inchiKey":"PPSNFPASKFYPMN-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEZOLINETANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ESN-364","Fezolinetant"],"crossReferences":{"drugbank":["DB15669"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL376044","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC2=NC(=O)/C(=C/c3ccc(C)o3)S2)cc1","inchiKey":"MXAPQGDBWFYKKX-ZROIWOOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376044","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08481"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833369","drugType":"Unknown","blackBoxWarning":false,"name":"FISH OIL","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["B1782","Fish oil"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2016 and has 1 investigational indication."}
{"id":"CHEMBL395308","canonicalSmiles":"O/N=C/c1ccc(-c2ccc(O)cc2)c2ccccc12","inchiKey":"VYQQTWUZKPWPRL-WOJGMQOQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL395308","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07150"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL39736","canonicalSmiles":"CCCC/N=C(/N)N=C(N)N","inchiKey":"XSEUMFJMFFMCIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFORMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Metabolism toxicity"],"year":1978},"tradeNames":[],"synonyms":["Buformin","Buformin hydrochloride","DBV","W 37"],"crossReferences":{"PubChem":["144205717","170465982","26757952"],"Wikipedia":["Buformin"],"drugbank":["DB04830"],"chEBI":["3209"]},"count":1,"approvedIndications":["EFO_0000400"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for diabetes mellitus. It was withdrawn in Germany  in 1978 due to Metabolism toxicity."}
{"id":"CHEMBL3989504","canonicalSmiles":"N[C@@H]1CN(c2c(F)cc3c(=O)c(C(=O)O)cn([C@@H]4C[C@@H]4F)c3c2Cl)CC12CC2.O","inchiKey":"ANCJYRJLOUSQBW-JJZGMWGRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITAFLOXACIN","maximumClinicalTrialPhase":2,"parentId":"CHEMBL108821","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DU-6859A","Sitafloxacin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989516","canonicalSmiles":"COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)([O-])[O-])C(=O)C(C)(C)O4)n2)cc(OC)c1OC.O.O.O.O.O.O.[Na+].[Na+]","inchiKey":"ZQGJCHHKJNSPMS-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSTAMATINIB DISODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103830","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tavalisse"],"synonyms":["Fostamatinib disodium","Fostamatinib disodium salt hexahydrate","R-788 SODIUM","R-788 SODIUM HYDRATE","R-935788 SODIUM","R-935788 SODIUM HYDRATE","R788 SODIUM","R788 SODIUM HYDRATE","R935788 SODIUM","R935788 SODIUM HYDRATE"],"crossReferences":{"DailyMed":["fostamatinib%20disodium"]},"count":6,"approvedIndications":["EFO_0007160"],"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0007160","EFO_0002690","EFO_0000574","EFO_1001264","EFO_0004194"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for autoimmune thrombocytopenic purpura and has 5 investigational indications."}
{"id":"CHEMBL3989865","canonicalSmiles":"C/C=C(/C)C(=O)O[C@H]1C(C)=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@@H](OC(=O)CCCCCCCCCCCNC(=O)C[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O)C[C@](C)(OC(C)=O)[C@H]2[C@@H]1OC(=O)CCCCCCC","inchiKey":"UPYNTAIBQVNPIH-ODMLWHIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIPSAGARGIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G-202","Mipsagargin"],"crossReferences":{"drugbank":["DB11813"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3989939","canonicalSmiles":"O=C(Nc1cnn2ccc(N3CCC[C@@H]3c3cc(F)ccc3F)nc12)N1CC[C@H](O)C1.O=S(=O)(O)O","inchiKey":"PXHANKVTFWSDSG-QLOBERJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAROTRECTINIB SULFATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3889654","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitrakvi"],"synonyms":["ARRY-470 SULFATE","LOXO-101 sulfate","Larotrectinib sulfate"],"crossReferences":{"DailyMed":["larotrectinib%20sulfate"]},"count":3,"approvedIndications":["EFO_0000616","EFO_0000311","EFO_0009708"],"linkedTargets":{"rows":["ENSG00000140538","ENSG00000148053","ENSG00000198400"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000311","EFO_0009708"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved indications."}
{"id":"CHEMBL3990016","drugType":"Antibody","blackBoxWarning":false,"name":"OLECLUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-9447","MEDI9447","Oleclumab"],"count":7,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3990018","drugType":"Antibody","blackBoxWarning":false,"name":"CERGUTUZUMAB AMUNALEUKIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cergutuzumab amunaleukin","RG-7813","RG7813","RO-6895882","RO6895882"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3990023","drugType":"Protein","blackBoxWarning":false,"name":"TOZULERISTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BLZ-100","Tozuleristide"],"count":5,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL408967","canonicalSmiles":"COc1cc2c(cc1OS(N)(=O)=O)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@H]2CC#N","inchiKey":"NTSPHKOMJMBWOU-NNKXXINSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL408967","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07596"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4217292","canonicalSmiles":"N#Cc1ccc(Cn2ccc(NC(=O)Cc3ccc(C4(C(F)(F)F)CC4)cc3)n2)nc1","inchiKey":"LSYANGLAZUZYFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACT-709478","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-709478","Act-709478"],"childChemblIds":["CHEMBL4204434"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297207","drugType":"Small molecule","blackBoxWarning":false,"name":"STANNSOPORFIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stanate"],"synonyms":["B-992","B992","Stanate","Stannsoporfin","Tin mesoporphyrin"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297298","canonicalSmiles":"CCc1c(O)cc(O)c(C(=O)c2ccc(OCCN3CCOCC3)c(OC)c2)c1CC(=O)N(CCOC)CCOC.Cl","inchiKey":"CKMGYWHSTADSIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KW-2478","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4300557","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kw-2478"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297371","canonicalSmiles":"[2H]C([2H])([2H])[C@H](O)C([2H])([2H])CCCn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"NSMXQKNUPPXBRG-WHPHVCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PCS-499","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4300766","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CTP-499","Ctp-499","PCS-499","PCS499","Pcs-499","Pcs499"],"crossReferences":{"drugbank":["DB15122"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297432","canonicalSmiles":"O=C(O)CN1C(=O)[C@@H](NC(=O)C2(C[C@@H](CCc3cccc4ccccc34)C(=O)O)CCCC2)CCc2ccccc21","inchiKey":"LOFDNSDPZTVIIO-VPUSJEBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SLV-334","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SLV334","Slv-334","Slv334"],"crossReferences":{"drugbank":["DB15356"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297474","canonicalSmiles":"C[C@@H](OP(=O)(N1CC1)N1CC1)c1ccc([N+](=O)[O-])c(Oc2cccc(C(=O)N(C)C)c2)c1","inchiKey":"NWGZZGNICQFUHV-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBI-3424","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OBI-3424","Obi-3424"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297491","canonicalSmiles":"C=CCN1CC(=O)N2[C@@H](Cc3ccc(O)cc3F)C(=O)N(Cc3cccc(N4CC(N5CCN(CC)CC5)C4)n3)C[C@@H]2N1C(=O)NCc1ccccc1","inchiKey":"ZGNKNLOBYFTGRG-GIWKVKTRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-7386","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7386","E7386"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297723","drugType":"Antibody","blackBoxWarning":false,"name":"CEMIPLIMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Libtayo"],"synonyms":["Cemiplimab","Cemiplimab-rwlc","REGN-2810","REGN2810","Regn2810"],"crossReferences":{"DailyMed":["cemiplimab-rwlc"]},"count":23,"approvedIndications":["EFO_0000616","EFO_0000707","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["MONDO_0015686","EFO_0000756","EFO_0000681","MONDO_0007254","EFO_1000044","MONDO_0002158","EFO_0003968","EFO_0009709","MONDO_0002974","EFO_0004193","EFO_0000183","EFO_0000707","EFO_0002618","EFO_0000616","MONDO_0008170","EFO_0004197","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1000026","MONDO_0002529","EFO_0000764","EFO_0000574","EFO_0001378","EFO_1001927","EFO_0000181","EFO_0000519","MONDO_0044926"],"count":28},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved and 20 investigational indications."}
{"id":"CHEMBL4297767","drugType":"Unknown","blackBoxWarning":false,"name":"HYLAN G-F 20","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hylan g-f 20"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297793","drugType":"Protein","blackBoxWarning":false,"name":"NANGIBOTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nangibotide"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297808","drugType":"Unknown","blackBoxWarning":false,"name":"PF-06823859","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06823859","PF06823859","Pf-06823859"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297854","drugType":"Unknown","blackBoxWarning":false,"name":"CABIOTRAXETAN LUTETIUM LU-177","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["177LU-ST2210","177lu-st2210","Cabiotraxetan lutetium lu-177","ST-2210 LU-177"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298051","drugType":"Unknown","blackBoxWarning":false,"name":"HAFNIUM OXIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hafnium oxide","NBTXR3","NSC-158931","Nbtxr3"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298093","drugType":"Antibody","blackBoxWarning":false,"name":"SEMORINEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MTAU-9937A","MTAU9937A","RO-7105705","RO7105705","Ro7105705","Semorinemab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298102","drugType":"Antibody","blackBoxWarning":false,"name":"VUNAKIZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SHR-1314","Shr-1314","Vunakizumab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298135","drugType":"Unknown","blackBoxWarning":false,"name":"NASTORAZEPIDE CALCIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nastorazepide calcium","Z-360"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL430266","canonicalSmiles":"COC[C@@H]([C@H](O)[C@H](O)C(=O)NCC[C@H](C)c1nc(/C=C/C[C@@H]2O[C@]3(C[C@@H](O)[C@@H]2C)O[C@H]([C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C(C)/C(C)=C/C=C/C(C)=C\\C#N)OC)[C@H](OP(=O)(O)O)C3(C)C)co1)N(C)C","inchiKey":"FKAWLXNLHHIHLA-YCBIHMBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALYCULIN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26755755"],"drugbank":["DB02860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL444","canonicalSmiles":"CCC1(CC)C(=O)NC(=O)NC1=O","inchiKey":"FTOAOBMCPZCFFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Barbital","Barbitone","Diemal","Diethylbarbituric acid"],"crossReferences":{"PubChem":["170465829","29215357"],"Wikipedia":["Barbital"],"drugbank":["DB01483"],"chEBI":["31252"]},"childChemblIds":["CHEMBL2105904"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL450656","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@@H]1C(=O)N1C[C@@H](O)C[C@@H]1C(=O)NCC(=O)N[C@H](C)C(=O)NCC(N)=O","inchiKey":"GFJRASPBQLDRRY-TWTQBQJDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ROTIGAPTIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GAP (WYETH)","Rotigaptide","ZP-123 (ZEALAND)"],"crossReferences":{"Wikipedia":["Rotigaptide"],"drugbank":["DB13067"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4534140","canonicalSmiles":"[2H]c1nc(Nc2ncc(F)c(-c3cc(F)c4nc(C)n(C(C)C)c4c3)n2)c([2H])c([2H])c1CN1CCN(C([2H])([2H])C([2H])([2H])[2H])CC1","inchiKey":"UZWDCWONPYILKI-BNMLNCJNSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4534140","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3301610","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4560026","canonicalSmiles":"Cc1c(F)cccc1NC(=O)Nc1ccc(Cl)c(S(=O)(=O)[C@H]2CCCNC2)c1O.Cl","inchiKey":"DYDXFXRQCUMHRP-YDALLXLXSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4560026","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3039531","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594278","canonicalSmiles":"COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1S(N)(=O)=O.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"AIJVJYUOMCRFOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEFAPIXANT CITRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3716057","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gefapixant citrate","MK-7264"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594404","canonicalSmiles":"CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCC(N(C)C6([C@@H]7CCN(c8c(F)cn9c(=O)c(C(=O)O)cc(C%10CC%10)c9c8C)C7)CC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\\C=C\\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H](C)[C@H](OC(C)=O)[C@H]1C","inchiKey":"OPZFMLLAJBIKAN-YSBZUPOXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TNP-2092","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tnp-2092"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594427","canonicalSmiles":"CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CNC(C)=O)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCCCCCCCCCCCC","inchiKey":"VITDDUXZOHEQMU-BYSUZVQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABX-196","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-196","ABX196","Abx-196","Abx196","PBS 96"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594563","drugType":"Unknown","blackBoxWarning":false,"name":"ISIS-463588","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IONIS-FGFR4RX","ISIS-463588","ISIS-FGFR4RX","Isis-463588","Isis-fgfr4rx"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594567","drugType":"Unknown","blackBoxWarning":false,"name":"KHK-4083","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KHK-4083","KHK4083","Khk-4083","Khk4083"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL479014","canonicalSmiles":"O=[N+]([O-])c1cccc2c(Br)n[nH]c12","inchiKey":"NFSTZPMYAZRZPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL479014","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11110834","11113670","124879386","124879387","124879390","26747128","26751855","26751856","50104555","50104556","50104557","50104558","85230935","90341482"],"drugbank":["DB01997"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483161","canonicalSmiles":"COc1ccccc1-c1ccc(NC(=O)/C(C#N)=C(/C)O)c(Cl)c1","inchiKey":"YUDQXOMZBLEWBH-KAMYIIQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL483161","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08172"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL492762","canonicalSmiles":"COc1cc(=O)n(C)c2c3c(ccc12)OCO3","inchiKey":"DPXXJCMMMXZVSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASIMIROIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Casimiroin"],"crossReferences":{"drugbank":["DB08744"],"chEBI":["3452"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL495","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O","inchiKey":"GMVPRGQOIOIIMI-DWKJAMRDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALPROSTADIL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alprostadil","Caverject","Caverject impulse","Edex","Prostin","Prostin vr","Prostin vr pediatric","Viridal 10","Viridal 20","Viridal 5","Viridal duo","Vitaros"],"synonyms":["Alprostadil","NSC-165559","ONO-1608","Pge1","Prostaglandin e1","U-10,136","U-10136"],"crossReferences":{"DailyMed":["alprostadil"],"PubChem":["144204033","49681576"],"Wikipedia":["Prostaglandin_E1"],"drugbank":["DB00770"],"chEBI":["15544"]},"count":11,"approvedIndications":["EFO_0004234","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000160951","ENSG00000125384"],"count":2},"linkedDiseases":{"rows":["MONDO_0002492","MONDO_0100130","EFO_0003875","EFO_1000809","EFO_0001645","EFO_0004234","EFO_0000401","EFO_0009085","EFO_0000556","EFO_0000319","MONDO_0008315","EFO_0002950","EFO_0009606","EFO_0004714","MONDO_0100096","EFO_1000820","MONDO_0000831","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0000612","EFO_0004265"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for cardiovascular disease and erectile dysfunction and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL495758","canonicalSmiles":"c1ccc2[nH]c(-c3cc[nH]n3)nc2c1","inchiKey":"IYTGPPNUOLLGBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL495758","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08065"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL502","canonicalSmiles":"COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2","inchiKey":"ADEBPBSSDYVVLD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DONEPEZIL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aricept","Donepezil","E-2020"],"crossReferences":{"DailyMed":["donepezil%20hydrochloride"],"PubChem":["50112790"],"Wikipedia":["Donepezil"],"drugbank":["DB00843"],"chEBI":["53289"]},"childChemblIds":["CHEMBL2171854","CHEMBL1678","CHEMBL2337271"],"count":21,"approvedIndications":["HP_0000726"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","EFO_0009386","EFO_0004718","HP_0000726","EFO_0000249","EFO_1001454","EFO_0003768","EFO_0009267","Orphanet_778","EFO_0004698","HP_0100543","EFO_0000289","MONDO_0002050","EFO_0000712","EFO_0003884","HP_0003419","EFO_0001064","EFO_0005230","EFO_0000692","EFO_1000158","EFO_0005762","EFO_0003756","HP_0002140","EFO_0002508","EFO_0003821","MONDO_0001020","EFO_0000701","Orphanet_240071","EFO_0003929","EFO_0003758","HP_0002381","EFO_0006792","EFO_0000311","Orphanet_908","EFO_0000546","EFO_0003885","EFO_0001072","EFO_0001360","EFO_0003918","EFO_0005411","MONDO_0002025"],"count":41},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for dementia and has 20 investigational indications."}
{"id":"CHEMBL503481","canonicalSmiles":"CCCCCCCCCCCCCCSCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CSCCCCCCCCCCCCCC","inchiKey":"ZZWQHNRGJQENEP-KXQOOQHDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHATIDYLCHOLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphatidylcholine"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL513225","canonicalSmiles":"O=C(c1c(O)cc(O)cc1O)n1cccc1","inchiKey":"RYGSNHBTZDYVSS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL513225","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08443"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL517712","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2","inchiKey":"RKUNBYITZUJHSG-SPUOUPEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATROPINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atroject","Atropen","Atrophate","Atropine","Atropine (autoinjector)","Isopto Atropine"],"synonyms":["Atropine"],"crossReferences":{"DailyMed":["atropine","atropine%20sulfate"],"PubChem":["11533003","144204367","144205143","144207685","56422449"],"drugbank":["DB00572"],"chEBI":["16684"]},"childChemblIds":["CHEMBL1200752","CHEMBL2146146","CHEMBL3185794","CHEMBL3182372"],"count":19,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":3},"linkedDiseases":{"rows":["HP_0000545","EFO_0005252","MONDO_0007254","HP_0004398","HP_0100543","EFO_1001865","EFO_0005758","EFO_1000645","EFO_0010581","EFO_0000253","HP_0011499","EFO_0005854","HP_0001662","EFO_0004210","HP_0000486","EFO_0009512","EFO_0005323","EFO_0002508","MONDO_0001020","HP_0002571","HP_0012803","EFO_0003843","HP_0002315","MP_0001914","EFO_0010282","EFO_1001121","Orphanet_230","EFO_0002614","EFO_0004888","EFO_0004209","HP_0001943","EFO_0009314","GO_0007596","EFO_0009492","EFO_0003956"],"count":35},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for gastrointestinal disease and has 18 investigational indications."}
{"id":"CHEMBL52125","canonicalSmiles":"CCN(CC)CCCN1c2ccccc2Sc2ccc(Cl)cc21","inchiKey":"DBOUGBAQLIXZLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPROETHAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorproethazine"],"crossReferences":{"drugbank":["DB13382"]},"childChemblIds":["CHEMBL2105938"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL525028","canonicalSmiles":"CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O","inchiKey":"VBUWHHLIZKOSMS-KDPLEQQTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VASOACTIVE INTESTINAL PEPTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vasoactive intestinal peptide","Vip"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL539648","canonicalSmiles":"O=C(O)/C=C\\C(=O)O","inchiKey":"VZCYOOQTPOCHFL-UPHRSURJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALEIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Maleic Acid"],"crossReferences":{"PubChem":["144206656","144209391","144213362","170465983","17389671","57268340"],"Wikipedia":["Maleic_acid"],"drugbank":["DB04299"],"chEBI":["18300"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54349","canonicalSmiles":"CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12","inchiKey":"JRTIDHTUMYMPRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPIDEM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1993},"tradeNames":[],"synonyms":["Alpidem","SL 80.0342-00"],"crossReferences":{"PubChem":["144207142","170466634"],"Wikipedia":["Alpidem"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1993 due to Hepatotoxicity."}
{"id":"CHEMBL549340","canonicalSmiles":"Nc1ncc(/N=N/c2ccccc2)c(-c2ccc(Cl)cc2Cl)n1","inchiKey":"UNJMNJFPEVJCQK-GHVJWSGMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549340","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08787"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL552128","canonicalSmiles":"C=C1CC[C@H]2[C@@H](/C=C(\\C)C(=O)[C@@]3(OC(C)=O)C[C@H](C)[C@H](OC(=O)c4ccccc4)[C@@H]3[C@H]1OC(C)=O)C2(C)C","inchiKey":"JPYYWXPAHJBKJX-VWSFRBHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL552128","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11260"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL557580","canonicalSmiles":"COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1.Cl","inchiKey":"VNRMGWLEPYHHBK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MURAGLITAZAR CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL186179","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Muraglitazar"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL564","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccccc21","inchiKey":"ZGUGWUXLJSTTMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROMAZINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-31447","Promazine"],"crossReferences":{"PubChem":["11111651","11111652","124881158","50100325","50104276","90341344"],"Wikipedia":["Promazine"],"drugbank":["DB00420"],"chEBI":["8459"]},"childChemblIds":["CHEMBL1200469"],"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["EFO_0005407","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956 and is indicated for psychosis."}
{"id":"CHEMBL583207","canonicalSmiles":"COc1ccc([C@@]23Oc4cc(OC)cc(OC)c4[C@]2(O)[C@H](O)[C@H](C(N)=O)[C@H]3c2ccccc2)cc1","inchiKey":"RMNPQEWLGQURNX-PXIJUOARSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIDESMETHYLROCAGLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Didesmethylrocaglamide"],"crossReferences":{"PubChem":["528941"],"drugbank":["DB15496"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL58323","canonicalSmiles":"COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1","inchiKey":"VPPJLAIAVCUEMN-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERLOSAMIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lacosamide","Vimpat"],"synonyms":["ADD 243037","ADD-243037","Erlosamide","Lacosamide","SPM 927","SPM-927"],"crossReferences":{"DailyMed":["lacosamide"],"PubChem":["170466190"],"Wikipedia":["Lacosamide"],"drugbank":["DB06218"]},"childChemblIds":["CHEMBL1213900"],"count":19,"approvedIndications":["EFO_0000474","HP_0001250"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["EFO_0005762","EFO_0008526","EFO_0003086","EFO_0005687","HP_0000726","EFO_0003821","HP_0001250","EFO_0003829","EFO_1000783","EFO_0000474","MONDO_0002050","EFO_0002506","EFO_0004263","EFO_0000326","EFO_0000253","EFO_0006510","EFO_0004149","EFO_0005230","EFO_0000692","EFO_0003833"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for seizure and epilepsy and has 17 investigational indications."}
{"id":"CHEMBL585902","canonicalSmiles":"Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O","inchiKey":"RQVKVJIRFKVPBF-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-548","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-548","Amg-548"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL588934","canonicalSmiles":"CC[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12","inchiKey":"LJOQGZACKSYWCH-WZBLMQSHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL588934","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13718"]},"childChemblIds":["CHEMBL596731"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL594722","canonicalSmiles":"NN1C(=O)N[C@@]2(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C1=O","inchiKey":"KLJXQBRQPPSXPZ-WWHASAIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL594722","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01843"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL601","canonicalSmiles":"NCC(=O)CCC(=O)O","inchiKey":"ZGXJTSGNIOSYLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOLEVULINIC ACID","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".delta.-aminolevulinic acid","Aminolevulinic acid","Levulan"],"crossReferences":{"DailyMed":["aminolevulinic%20acid%20hydrochloride"],"PubChem":["56322917"],"Wikipedia":["Aminolevulinic_acid"],"drugbank":["DB00855"],"chEBI":["17549"]},"childChemblIds":["CHEMBL18851","CHEMBL1200582","CHEMBL3350765","CHEMBL3350389"],"count":18,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for neoplasm and has 17 investigational indications."}
{"id":"CHEMBL61946","canonicalSmiles":"CCN(CC)CCOC(=O)C1(c2ccccc2)CCCC1","inchiKey":"OFAIGZWCDGNZGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARAMIPHEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caramiphen"],"crossReferences":{"drugbank":["DB11504"]},"childChemblIds":["CHEMBL1598472","CHEMBL2355683"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL64677","canonicalSmiles":"O=C1C(O)N=C(c2ccccc2F)c2cc(Cl)ccc2N1CCO","inchiKey":"VOJLELRQLPENHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXEFAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Doxefazepam"],"crossReferences":{"Wikipedia":["Doxefazepam"],"drugbank":["DB13837"],"chEBI":["82460"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL66424","canonicalSmiles":"C=CCN(C)CCCCCCOc1ccc2c(-c3ccc(Br)cc3)nn(C)c2c1","inchiKey":"FNZKIJOTNKEJBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL66424","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03888"]},"childChemblIds":["CHEMBL115497"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL68117","canonicalSmiles":"CN[C@H]1CN(c2ccc3c(=O)c(C(=O)O)cn(-c4nccs4)c3n2)C[C@@H]1OC","inchiKey":"XZAFZXJXZHRNAQ-STQMWFEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOSAROXIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AG-7352","SNS-595","SPC-595","Voreloxin","Vosaroxin"],"crossReferences":{"drugbank":["DB11999"]},"childChemblIds":["CHEMBL543336"],"count":8,"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000565","EFO_0000339","EFO_0000220","EFO_0000702","EFO_0000222","EFO_0003060"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL719","canonicalSmiles":"C/C(=C\\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O","inchiKey":"MINDHVHHQZYEEK-HBBNESRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MUPIROCIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bactroban","Centany","Mupirocin"],"synonyms":["BRL 4910A","BRL-4910A","Bactroban","Mupirocin","Pseudomonic acid"],"crossReferences":{"DailyMed":["mupirocin","mupirocin%20calcium"],"PubChem":["144205736","47193668","50111691"],"Wikipedia":["Mupirocin"],"drugbank":["DB00410"],"chEBI":["7025"]},"childChemblIds":["CHEMBL3989715","CHEMBL2068726"],"count":10,"approvedIndications":["HP_0001742"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for nasal obstruction and has 9 investigational indications."}
{"id":"CHEMBL7303","canonicalSmiles":"COC(=O)C1=CCCN(C)C1","inchiKey":"HJJPJSXJAXAIPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARECOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["104171107","11110758","11110759","124879235","144203630","170466659","26755647","90341790"],"Wikipedia":["Arecoline"],"drugbank":["DB04365"],"chEBI":["2814"]},"childChemblIds":["CHEMBL449209"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL75753","canonicalSmiles":"O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1","inchiKey":"DXPOSRCHIDYWHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XAMOTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Xamoterol"],"crossReferences":{"PubChem":["104171266","144203855"],"Wikipedia":["Xamoterol"],"drugbank":["DB13781"],"chEBI":["10055"]},"childChemblIds":["CHEMBL1329567","CHEMBL1256945","CHEMBL2104466"],"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL76232","canonicalSmiles":"N[C@H](CCC(=O)O)C(=O)O","inchiKey":"WHUUTDBJXJRKMK-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-GLUTAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E620","Glutamic acid"],"crossReferences":{"PubChem":["11111223","11113411","144206603","26751650","26751651"],"drugbank":["DB02517"],"chEBI":["15966"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL83","canonicalSmiles":"CC/C(=C(\\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1","inchiKey":"NKANXQFJJICGDU-QPLCGJKRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TAMOXIFEN","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ICI-46474","ICI-47699","Nolvadex","Soltamox","Tamoxifen"],"crossReferences":{"DailyMed":["tamoxifen%20citrate"],"PubChem":["11113844","144208441","144210857","26752017","26752018","50104683","50104684","50104685","50104686","56320712","90340643"],"TG-GATEs":["54"],"Wikipedia":["Tamoxifen"],"drugbank":["DB00675"],"chEBI":["41774"]},"childChemblIds":["CHEMBL786"],"count":3,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_1000403","EFO_0000637","EFO_0001075","EFO_1001901","MONDO_0007254","MONDO_0002087","EFO_0000305","HP_0000771","EFO_1000984","MONDO_0001187","MONDO_0002158","EFO_0000289","EFO_1001375","EFO_0000389","EFO_0006890","EFO_1000251","EFO_0000326","EFO_0000253","MONDO_0004647","EFO_1000158","EFO_0001416","EFO_0000616","MONDO_0007608","Orphanet_145","EFO_0000545","MONDO_0004658","MONDO_0008170","EFO_1001512","EFO_0000232","EFO_0003843","EFO_0000660","MONDO_0008315","EFO_0000537","EFO_0000311","EFO_0000294","Orphanet_98896","MP_0001914","EFO_0000304","Orphanet_398934","EFO_0009708","MONDO_0002691","MONDO_0100096","EFO_0004220","EFO_0006861","EFO_0000764","MONDO_0011962","Orphanet_774","EFO_0000432","MONDO_0024880","EFO_0000519","EFO_0003922"],"count":52},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for neoplasm and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL831","canonicalSmiles":"CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1","inchiKey":"XJGVXQDUIWGIRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOXAPINE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adasuve","Loxitane intramuscular [as hydrochloride]","Loxitane-c oral suspension [as hydrochloride]"],"synonyms":["CL 62,362","CL-62362","Loxapac","Loxapine","Loxitane","SUM 3170","SUM-3170"],"crossReferences":{"DailyMed":["loxapine"],"PubChem":["50103874","50104024","50104025","50104026","90341467"],"Wikipedia":["Loxapine"],"drugbank":["DB00408"],"chEBI":["50841"]},"childChemblIds":["CHEMBL1201155","CHEMBL1201060"],"count":9,"approvedIndications":["EFO_0005407","HP_0000713"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003821","EFO_0000270","EFO_0009963","EFO_0005407","EFO_0000341","EFO_0003768","EFO_0005230","EFO_0000692","HP_0000713"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and is indicated for psychosis and agitation and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL945","canonicalSmiles":"N=C(N)NC(=O)c1nc(Cl)c(N)nc1N","inchiKey":"XSDQTOBWRPYKKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMILORIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amiloride","Hydro-Ride","Midamor"],"crossReferences":{"DailyMed":["amiloride%20hydrochloride"],"PubChem":["104171108","11110775","11113372","124879259","124879263","144203631","170465124","26751628","26751629","49645530","90341609"],"Wikipedia":["Amiloride"],"drugbank":["DB00594"],"chEBI":["2639"]},"childChemblIds":["CHEMBL1201085","CHEMBL1398126","CHEMBL540851"],"count":10,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000111319"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0007405","EFO_0004269","HP_0000093","EFO_0001645","Orphanet_586","EFO_0000373","EFO_0000319","EFO_0000537","HP_0011096","EFO_0008519","EFO_0003884","EFO_0005295","EFO_1002032","EFO_0008522"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for cardiovascular disease and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL975","canonicalSmiles":"O=S(=O)([O-])CCS.[Na+]","inchiKey":"XOGTZOOQQBDUSI-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MESNA","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1098319","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mesna","Mesnex","Mistabron","Uromitexan"],"synonyms":["D 7093","D-7093","Mesna","NSC-113891"],"crossReferences":{"PubChem":["144208061","170464862","26748569","555156"],"Wikipedia":["Mesna"]},"count":45,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 45 investigational indications."}
{"id":"CHEMBL97972","canonicalSmiles":"O=[N+]([O-])c1c(Cl)cccc1-c1c[nH]cc1Cl","inchiKey":"QJBZDBLBQWFTPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRROLNITRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["52230","Pyrrolnitrin"],"crossReferences":{"PubChem":["144206296","50125849"],"drugbank":["DB13603"],"chEBI":["32079"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL982","canonicalSmiles":"C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5","inchiKey":"WJBLNOPPDWQMCH-MBPVOVBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALMEFENE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Selincro"],"synonyms":["JF-1","Nalmefene","Nalmetrene","ORF 1167","ORF 11676","ORF-1167","ORF-11676","Revex","SRD-174","SRD174"],"crossReferences":{"PubChem":["144204424","170465281","50103951","855608"],"Wikipedia":["Nalmefene"],"drugbank":["DB06230"],"chEBI":["7457"]},"childChemblIds":["CHEMBL1201152"],"count":6,"approvedIndications":["EFO_0003829"],"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0004319","EFO_0003086","EFO_0000274","EFO_0004699","EFO_0005611","EFO_0003829"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for alcohol dependence and has 5 investigational indications."}
{"id":"CHEMBL984","canonicalSmiles":"COc1cc2c(cc1OC)[C@@H](Cc1cc(OC)c(OC)c(OC)c1)[N+](C)(CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2.[Cl-].[Cl-]","inchiKey":"WMSYWJSZGVOIJW-ONUALHDOSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MIVACURIUM CHLORIDE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1182833","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mivacron","Mivacurium chloride"],"synonyms":["BW B109OU DICHLORIDE","BW-1090U DICHLORIDE","BW-B109OU","BW-B109OU DICHLORIDE","BWB109OU","Mivacurium chloride","mivacurium"],"crossReferences":{"PubChem":["144206026"],"Wikipedia":["Mivacurium_chloride"]},"count":1,"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["HP_0001410"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and has 1 investigational indication."}
{"id":"CHEMBL99889","canonicalSmiles":"O=C(N[C@@H](Cc1ccc(F)cc1)C(=O)N1CCC(O)CC1)c1cc2cc(Cl)ccc2[nH]1","inchiKey":"YDCGVASFVACWKF-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-320626","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-320626"],"crossReferences":{"drugbank":["DB03383"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
